ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends VRAYQ vs. IONM, AHPI, BRSH, MOTS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, and BRSHWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include Assure (IONM), Allied Healthcare Products (AHPI), Bruush Oral Care (BRSH), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), and Bruush Oral Care (BRSHW). These companies are all part of the "medical equipment" industry. ViewRay vs. Assure Allied Healthcare Products Bruush Oral Care Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care ViewRay (NASDAQ:VRAYQ) and Assure (NASDAQ:IONM) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk, community ranking and dividends. Does the media prefer VRAYQ or IONM? In the previous week, ViewRay's average media sentiment score of 0.00 equaled Assure'saverage media sentiment score. Company Overall Sentiment ViewRay Neutral Assure Neutral Which has more volatility & risk, VRAYQ or IONM? ViewRay has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Assure has a beta of 1.84, meaning that its stock price is 84% more volatile than the S&P 500. Which has stronger valuation & earnings, VRAYQ or IONM? Assure has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/AAssure$250K0.00-$26.08MN/AN/A Do institutionals & insiders have more ownership in VRAYQ or IONM? 15.5% of ViewRay shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 2.5% of ViewRay shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is VRAYQ or IONM more profitable? ViewRay has a net margin of 0.00% compared to Assure's net margin of -25,178.32%. Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A Assure -25,178.32%N/A -249.78% Does the MarketBeat Community favor VRAYQ or IONM? Assure received 3 more outperform votes than ViewRay when rated by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/AAssureOutperform Votes327.27% Underperform Votes872.73% SummaryViewRay and Assure tied by winning 4 of the 8 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18,000.00$3.37B$5.84B$9.15BDividend YieldN/A1.64%4.75%3.85%P/E RatioN/A16.9226.3819.16Price / SalesN/A73.24435.3370.72Price / CashN/A44.0938.0134.83Price / BookN/A3.857.644.62Net Income-$107.33M$92.00M$3.19B$246.06M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18,000.00$102.21M0.00300IONMAssureN/A$0.01flatN/AN/A$31,000.00$250,000.000.00130Gap DownAHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Analyst ForecastGap UpBRSHBruush Oral CareN/A$0.00flatN/A-97.4%$1,000.00$2.92M0.0011Gap UpMOTSMotus GIN/A$0.00-50.0%N/A-100.0%$1,000.00$319,000.000.0030Gap DownVIVEViveve MedicalN/A$0.00-50.0%N/A+0.0%$1,000.00$6.83M0.0070Gap DownDRTSWAlpha Tau MedicalN/A$0.35-1.7%N/A+12.0%$0.00N/A0.0080Gap UpANZUWAnzu Special Acquisition Corp IN/A$0.04-9.9%N/A+163.0%$0.00N/A0.002High Trading VolumeATAKWAurora Technology AcquisitionN/A$0.03+1.3%N/A+20.0%$0.00N/A0.00N/AGap UpHigh Trading VolumeBBLGWBone BiologicsN/A$95.00+5.8%N/A+756.9%$0.00N/A0.002Gap DownBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011 Related Companies and Tools Related Companies Assure Alternatives Allied Healthcare Products Alternatives Bruush Oral Care Alternatives Motus GI Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VRAYQ) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRAYQ Stock Alerts